Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 5;14(8):2315.
doi: 10.4081/jphia.2023.2315. eCollection 2023 Aug 7.

Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic

Alexandre Manirakiza  1   2 , Christian Malaka  1 , Jean de Dieu Longo  2   3 , Brice Martial Yambiyo  1 , Saint-Calver Henri Diemer  2 , Joella Namseneï  1 , Cathy Sandra Gomelle Coti-Reckoundji  1 , Modeste Bouhouda  1 , Marie Roseline Darnycka Belizaire  4 , Jean Baptiste Roungou  3 , Narcisse Patrice Komas  1   2 , Gérard Grésenguet  2 , Guy Vernet  1 , Marie-Astrid Vernet  1 , Emmanuel Nakoune  1   2
Affiliations

Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic

Alexandre Manirakiza et al. J Public Health Afr. .

Abstract

Background: Large-scale population-based seroprevalence studies of SARS-CoV-2 are essential to characterize the cumulative incidence of SARS-CoV-2 infection and to extrapolate the prevalence of presumptive immunity at the population level. Objective. The objective of our survey was to estimate the cumulative population immunity for COVID-19 and to identify individual characteristics associated with positive serostatus.

Materials and methods: This was a clustered cross-sectional study conducted from July 12 to August 20, 2021, in households in the city of Bangui, the capital of the Central African Republic. Information regarding demographic characteristics (age, gender, and place of residence), and comorbidities (chronic diseases) was collected. A venous blood sample was obtained from each participant to determine the level of total anti-SARS-CoV-2 antibodies using a WANTAI SARS-CoV-2 Ab ELISA kit.

Results: All up, 799 participants were surveyed. The average age was 27 years, and 45.8% of the respondents were male (sex ratio: 0.8). The overall proportion of respondents with positive serostatus was 74.1%. Participants over 20 years of age were twice as likely to have positive serostatus, with an OR of 2.2 [95% CI: (1.6, 3.1)].

Conclusions: The results of this survey revealed a high cumulative level of immunity in Bangui, thus indicating a significant degree of spread of SARS-CoV-2 in the population. The public health implications of this immunity to SARS-CoV-2 such as the post-vaccination total antibody kinetics remain to be determined.

Keywords: Bangui; Central African Republic; SARS-CoV-2; cumulative immunity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: the authors declare no potential conflict of interest.

Figures

Figure 1.
Figure 1.
COVID-19 seroprevalence mapping in Bangui, Central African Republic, July-August 2021.
See this image and copyright information in PMC

References

    1. WHO. WHO Director-General’s statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). Available from: https://wwwwhoint/director-general/speeches/detail/who-director-general-... (2019-ncov (accessed on 20 February 2020).
    1. Kadi N, Khelfaoui M. Population density, a factor in the spread of COVID-19 in Algeria: statistic study. Bull Natl Res Cent 2020;44:138. - PMC - PubMed
    1. Helmy YA, Fawzy M, Elaswad A, et al. . The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. J Clin Med 2020;9. - PMC - PubMed
    1. Patel EU, Bloch EM, Tobian AAR. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serosurveillance in Blood Donor Populations. J Infect Dis 2021. - PubMed
    1. Rostami A, Sepidarkish M, Leeflang MMG, et al. . SARS-CoV- 2 seroprevalence worldwide: a systematic review and metaanalysis. Clin Microbiol Infect 2021;27:331-40. - PMC - PubMed

LinkOut - more resources